Prof Kirsten Morley (@drkirstenmorley) 's Twitter Profile
Prof Kirsten Morley

@drkirstenmorley

Professor @USYD/RPAH/ECC. Director of Addiction Treatment Research Theme. Alcohol, mental health, treatment, translation

ID: 1132537353564708865

calendar_today26-05-2019 06:42:01

601 Tweet

689 Followers

619 Following

Shalini Arunogiri (@sarunogiri) 's Twitter Profile Photo

We're looking for a research #nurse at Turning Point to support exciting clinical trials in #alcohol #methamphetamine Passionate about #AOD and innovation? Considering dipping your toe in #research? This might be the job for you! Apply by 12th April: eh.mercury.com.au/ViewPosition.a…

Emily G Cunningham MBE (@eg_cunningham) 's Twitter Profile Photo

🧵4/n It’s only now that I’ve left that I can really begin to process my Antarctic experience. And only now that I’ve left can I let myself acknowledge the canary in the coal mine… This wonderful place is dying.

🧵4/n 

It’s only now that I’ve left that I can really begin to process my Antarctic experience. 

And only now that I’ve left can I let myself acknowledge the canary in the coal mine… 

This wonderful place is dying.
Edith Collins Centre (@edith__collins) 's Twitter Profile Photo

Are you a health professional who wants to learn more about the NSW Alcohol Interlock Program & Driver Medical Reviews? Then be sure to register for our new webinar by Prof Kate Conigrave & Prof Paul Haber on Wednesday 31st May from 7pm (AEST). More info: uni-sydney.zoom.us/meeting/regist…

Are you a health professional who wants to learn more about the NSW Alcohol Interlock Program & Driver Medical Reviews?

Then be sure to register for our new webinar by Prof <a href="/KConigrave/">Kate Conigrave</a> &amp; Prof Paul Haber on Wednesday 31st May from 7pm (AEST). 

More info: uni-sydney.zoom.us/meeting/regist…
Biological Psychiatry Australia (@biolpsychaust) 's Twitter Profile Photo

Join us on THRUSDAY 18 MAY for our first webinar of the year: SUBSTANCE USE DISORDER: FROM TRANSLATIONAL ANIMAL MODELS TO NOVEL CLINICAL TRIALS Featuring presentations by Xavier Maddern, Christina Perry, Dr Alexandre GuĆ©rin , and Warren Logge. Registration: us02web.zoom.us/webinar/regist…

Join us on THRUSDAY 18 MAY for our first webinar of the year: 

SUBSTANCE USE DISORDER: FROM TRANSLATIONAL ANIMAL MODELS TO NOVEL CLINICAL TRIALS

Featuring presentations by Xavier Maddern, <a href="/Dr_CJP/">Christina Perry</a>, <a href="/alex_guerin13/">Dr Alexandre GuƩrin</a> , and <a href="/WarrenLogge/">Warren Logge</a>.

Registration: us02web.zoom.us/webinar/regist…
JBI EVIDENCE IMPLEMENTATION (@jbi_ei) 's Twitter Profile Photo

There is a high prevalence of comorbid drug/alcohol and mental health disorders, and there is an #implementation gap in the provision of evidence-based treatments for this population. #JBIMethodology A JBI EVIDENCE IMPLEMENTATION original research paper: rb.gy/poks0 #WorldEBHCDay

There is a high prevalence of comorbid drug/alcohol and mental health disorders, and there is an #implementation gap in the provision of evidence-based treatments for this population.    #JBIMethodology
A <a href="/JBI_EI/">JBI EVIDENCE IMPLEMENTATION</a> original research paper: rb.gy/poks0 #WorldEBHCDay
NSW Medical Research (@medresearchnsw) 's Twitter Profile Photo

After receiving a NSW Health Grant in 2016, University of Sydney researchers Paul Haber & Prof Kirsten Morley demonstrate a multimodal training approach can improve ID & treatment of mental health conditions in people with substance use disorder. Learn more: medicalresearch.nsw.gov.au/forging-a-path…

After receiving a <a href="/NSWHealth/">NSW Health</a> Grant in 2016, <a href="/Sydney_Uni/">University of Sydney</a> researchers Paul Haber &amp; <a href="/DrKirstenMorley/">Prof Kirsten Morley</a> demonstrate a multimodal training approach can improve ID &amp; treatment of mental health conditions in people with substance use disorder. Learn more: medicalresearch.nsw.gov.au/forging-a-path…
Edith Collins Centre (@edith__collins) 's Twitter Profile Photo

Hypothalamic-pituitary-adrenocortical response in alcohol-dependent patients during baclofen treatment and associat… pubmed.ncbi.nlm.nih.gov/37244449/

Shalini Arunogiri (@sarunogiri) 's Twitter Profile Photo

Looking forward to joining ABC RN Radio National tomorrow at 0905 to join the Life Matters team and discuss #psychedelic assisted therapy #PAT Tune in at abc.net.au/listen/program… to hear about implementation in Australia, knowns & unknowns, and about our trial Prof Kirsten Morley

Prof Kirsten Morley (@drkirstenmorley) 's Twitter Profile Photo

Head to head genotype-stratified trial of topiramate vs naltrexone! Topiramate was as effective and safe as naltrexone, but superior on some outcomes. There were no sig effects of rs2832407 nor rs1799971 TREAT: Translational Research in Alcohol Treatment Sydney Research Sydney Health ajp.psychiatryonline.org/doi/abs/10.117…

Journals of The American Psychiatric Association (@apapubjournals) 's Twitter Profile Photo

A study comparing topiramate with naltrexone found topiramate to be at least as effective and safe as the first-line medication naltrexone in reducing heavy alcohol consumption and superior in reducing some clinical outcomes. Prof Kirsten Morley bit.ly/3wV1NQA

A  study comparing topiramate with naltrexone found topiramate to be at least as effective and safe as the first-line medication naltrexone in reducing heavy alcohol consumption and superior in reducing some clinical outcomes. <a href="/DrKirstenMorley/">Prof Kirsten Morley</a> bit.ly/3wV1NQA